Antiphospholipid syndrome (APS) is a thrombo-inflammatory disease propelled by
circulating autoantibodies that recognize cell surface phospholipids and phospholipid …

Antiphospholipid syndrome (APS) is an acquired autoimmune disease defined by the
presence of persistently positive antiphospholipid antibodies (aPLs) on two or more …

Objective aPL are found in the blood of 20–30% of patients with SLE. Although aPL cause
vascular thrombosis in the antiphospholipid syndrome, it is not clear whether positive aPL …

Anti-β2GPI antibodies (aβ2GPI) are one of the laboratory criteria for antiphospholipid
syndrome (APS), along with lupus anticoagulant (LA) and anticardiolipin antibodies (aCL). A …

Antiphospholipid syndrome (APS) is an autoimmune thrombophilia that is characterised by
thrombosis and obstetric complications in the presence of antiphospholipid antibodies …

Background/aim: In this cross-sectional study, it was aimed to test the predictive value of
noncriteria antiphospholipid antibodies (aPL) in addition to the global antiphospholipid …

Despite recent advances in treatment and significant improvements in prognosis, thrombosis
remains the major cause of death in systemic lupus erythematosus (SLE). Antiphospholipid …

Background Antibodies to β2-glycoprotein I (β2GPI) cause thrombosis in antiphospholipid
syndrome, however the role of β2GPI itself in regulation of coagulation pathways in vivo is …

Utilidad de biomarcadores no incluidos en los criterios de clasificación para la identificación y
seguimiento de pacientes con Page 1 UNIVERSIDAD COMPLUTENSE DE MADRID FACULTAD …

Background: Antiphospholipid syndrome (APS) is a multisystemic autoimmune disorder
characterized by thrombotic events and/or gestational morbidity in patients with …